IELTS Reading: Health & Medicine

Paragraph A For much of the twentieth century, the dominant concern of public health systems across the world was the control of infectious disease. Smallpox, tuberculosis, and cholera commanded the attention of governments, international agencies, and medical researchers alike. Yet as vaccination programmes, improved sanitation, and the widespread availability of antibiotics brought many communicable diseases under control in high-income nations, a new and arguably more complex health challenge began to emerge. Non-communicable diseases — those not transmitted from person to person, including cardiovascular disease, type 2 diabetes, chronic respiratory conditions, and certain cancers — have become the leading cause of premature death globally. According to the World Health Organization, non-communicable diseases account for approximately 74 percent of all deaths worldwide each year, with low- and middle-income countries bearing a disproportionately heavy share of this burden.

Paragraph B The epidemiological transition through which societies shift from infectious to chronic disease as their primary health concern is closely linked to changes in lifestyle, diet, and economic development. Urbanisation has played a particularly significant role: as populations have migrated from rural areas to cities, traditional dietary patterns rich in whole grains and vegetables have given way to processed, calorie-dense foods high in sodium, refined sugars, and saturated fats. Physical activity levels have declined simultaneously, as mechanised transport and sedentary employment have replaced more physically demanding ways of life. Dr Anita Rao of the Institute for Global Health Research in Geneva has argued that urbanisation functions as an 'accelerant' for chronic disease risk factors, compressing into a single generation transitions that took several decades in industrialised nations. Evidence from longitudinal studies conducted across sub-Saharan Africa between 2005 and 2018 appears to support this view, demonstrating that urban residents in that region showed significantly elevated rates of hypertension compared with their rural counterparts.

Paragraph C The financial implications of this transition are considerable. Chronic diseases are characterised by long duration and frequently require ongoing medical management, placing sustained pressure on healthcare infrastructure. A 2019 analysis published in The Lancet estimated that the cumulative economic cost of cardiovascular disease alone — including both direct medical expenditure and indirect losses through reduced productivity — could reach 47 trillion US dollars globally over the following three decades. Health systems in lower-income settings are particularly vulnerable, since they were largely constructed to address acute infectious conditions and may lack the specialist facilities, trained personnel, and pharmaceutical supply chains necessary to manage complex long-term illnesses. Consequently, many patients in these contexts receive a diagnosis only once their condition has advanced to a stage where treatment is substantially more costly and less effective.

Paragraph D Prevention, rather than treatment, is now widely regarded by public health authorities as the most sustainable response to the non-communicable disease burden. Interventions targeting modifiable risk factors — tobacco use, harmful alcohol consumption, physical inactivity, and poor diet — have demonstrated considerable potential when implemented at a population level. Sugar-sweetened beverage taxes introduced in Mexico in 2014 were associated with a measurable reduction in consumption among lower-income households, according to research published in the British Medical Journal. Similarly, comprehensive tobacco control policies combining advertising restrictions, plain packaging requirements, and taxation have produced sustained declines in smoking prevalence across multiple countries. Nevertheless, critics argue that behavioural interventions place an excessive burden of responsibility on individuals, overlooking the structural and commercial determinants that shape unhealthy choices.

Paragraph E Medical research has also begun to reorient itself in response to the shifting disease landscape. Precision medicine — an approach that seeks to tailor treatment to the genetic, environmental, and lifestyle characteristics of individual patients — has attracted substantial investment from both public research councils and private pharmaceutical companies. Proponents suggest that this paradigm could transform outcomes for conditions such as certain cancers, where current treatments remain insufficiently targeted. However, there is a growing concern among bioethicists and health economists that precision medicine primarily benefits those in wealthy nations who can access advanced diagnostic technologies, potentially widening rather than narrowing global health inequalities. Whether the promise of highly individualised therapies can be reconciled with the imperative to extend basic healthcare to underserved populations remains, for the moment, an unresolved question at the heart of contemporary medical thinking.

Paragraph F The trajectory of global health in the coming decades will be shaped by how effectively societies manage this dual reality: the persistence of infectious disease threats, illustrated starkly by the COVID-19 pandemic, alongside the relentless growth of the chronic disease burden. Integrated health systems capable of addressing both dimensions simultaneously, rather than oscillating between one priority and another, are likely to prove most resilient. Building such systems demands not only sustained financial investment but also a fundamental reconsideration of the social, economic, and environmental conditions that determine who becomes ill, and why.